Kwality (KPL) | Stock Overview & Key Data
Kwality Performance Comparison
Stock Range
Today's Range
Low: ₹1,010.00
High: ₹1,040.00
on August 22, 2025
52 Week Range
Low: ₹596.05
High: ₹1,235.00
on March 4, 2025
on July 7, 2025
All-Time High: ₹1,235.00 on July 7, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR11.0B
EPS
41.80
P/E Ratio (TTM)
25.44
Forward P/E
N/A
P/B Ratio
4.18
PEG Ratio
0.59
Div. Yield
N/A
ROE
15.19%
Beta
-0.178
Debt to Equity
42.85
Financial Highlights
Profitability
Gross Margin
47.94%
Operating Margin
17.75%
Profit Margin
10.81%
Returns and Earnings
Return on Assets (TTM)
8.91%
Return on Equity (TTM)
15.19%
EBITDA
INR892.4M
Net Income (TTM)
INR434.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR387.04
Quarterly Revenue Growth (YoY)
39.20%
Quarterly Earnings Growth (YoY)
42.70%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Kwality KPL | 11.03B Small-cap | 1.27% | -11.51% | 6.54% | 45.37% | 16.77% | 40.60% | 248.32% | 2,317.06% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | 0.56% | -2.16% | -4.47% | 0.14% | -13.13% | -7.54% | 86.54% | 195.42% |
| Divi's Laboratories DIVISLAB | 1.64T Large-cap | -0.21% | -6.98% | -5.91% | 7.87% | 1.29% | 26.68% | 71.47% | 87.96% |
| Sun Pharma Advanced SPARC | 47.77B Small-cap | 1.72% | -7.23% | -10.11% | 14.74% | -27.21% | -34.43% | -37.13% | -23.18% |
| Aarti Drugs AARTIDRUGS | 42.99B Small-cap | -4.13% | -10.00% | 1.76% | 27.10% | 6.05% | -14.34% | 10.27% | -34.08% |
| Sequent Scientific SEQUENT | 44.30B Small-cap | 0.12% | -6.92% | -2.35% | 12.64% | -4.77% | 5.41% | 52.52% | 30.60% |
Ownership & Short Interest
Insider Ownership
76.85%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
26K
Average 90-Day Volume
23K
Kwality Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Kwality would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is KPL's 52-week high and low?
- In the last 52 weeks, Kwality reached a high of ₹1,235.00 (on July 7, 2025) and a low of ₹596.05 (on March 4, 2025).
- What is the market cap and P/E ratio for KPL?
- Curious about Kwality's size and valuation? Its market capitalization stands at 11.03B. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.44, and the forward P/E (looking ahead) is N/A.
- Does KPL pay dividends? If so, what's the yield?
- As for dividends, Kwality isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Kwality's main competitors or similar companies to consider before investing?
When looking at Kwality, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -7.54% 86.54% Divi's Laboratories
DIVISLAB1.64T Healthcare Drug Manufacturers - Specialty & Generic 26.68% 71.47% Sun Pharma Advanced
SPARC47.77B Healthcare Drug Manufacturers - Specialty & Generic -34.43% -37.13% Aarti Drugs
AARTIDRUGS42.99B Healthcare Drug Manufacturers - Specialty & Generic -14.34% 10.27% Sequent Scientific
SEQUENT44.30B Healthcare Drug Manufacturers - Specialty & Generic 5.41% 52.52% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Kwality Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Kwality's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.19%, the Debt to Equity ratio from the most recent quarter is 42.85, and its Gross Profit Margin stands at 47.94%.
- What is the recent revenue and earnings growth for KPL?
- Looking at Kwality's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 39.20%, and quarterly earnings saw a YoY growth of 42.70%.
- How much of KPL stock is held by insiders and institutions?
- Wondering who owns Kwality stock? Company insiders (like executives and directors) hold about 76.85% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.